Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bifurcation, quasi-periodic dynamics, chaos, and soliton waves in the van der Waals normal form for fluidized granular matter.

Scientific reports·2026
Same author

Antibacterial and antioxidant potentials of larval extract of black soldier fly, <i>Hermetia illucens</i> and blow fly, <i>Lucilia sericata</i>, for biomedical applications.

Biotechnologia·2026
Same author

Mathematical modelling and analysis of human metapneumovirus transmission dynamics using neural network intelligence and optimal control.

Computational biology and chemistry·2026
Same author

Vaping and mental health: A cross-sectional study among university students in Bangladesh.

PloS one·2026
Same author

Dynamics of soliton propagation: bifurcation, chaos, and quantitative insights into the modified Camassa-Holm equation.

Scientific reports·2026
Same author

A seven-band co-integrated antenna for 5G/6G operations in sub-6 GHz and millimeter-wave frequencies.

Scientific reports·2025
Same journal

Feasibility Study of Combined Systemic Therapy and Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Patients.

Cancer medicine·2026
Same journal

A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor-Associated Immune Cell Infiltration Abundance.

Cancer medicine·2026
Same journal

Robotic Partial Nephrectomy: Different Surgical Approaches for Different Locations.

Cancer medicine·2026
Same journal

Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.

Cancer medicine·2026
Same journal

Survival of Hematologic Malignancy In Patients With Early-Stage Chronic Kidney Disease (SHIP-CKD).

Cancer medicine·2026
Same journal

Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study.

Cancer medicine·2026
See all related articles
  1. Home
  3. Biopharmaceuticals For Cancer Treatment: An Update.
  1. Home
  3. Biopharmaceuticals For Cancer Treatment: An Update.

Related Experiment Video

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

9.8K

Biopharmaceuticals for Cancer Treatment: An Update.

Anupom Deb Nath1, Yousuf Alam2, Afsana Mustak Mim2

  • 1Faculty of Biotechnology and Genetic Engineering, Sylhet Agricultural University, Sylhet, Bangladesh.

Cancer Medicine
|April 10, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

This review explores potential anticancer drug targets and discusses approved biopharmaceutical cancer therapies, highlighting their expanding role in treatment and patient survival. It examines current challenges and future directions in cancer drug development.

Keywords:
anticancer drugsapproved cancer drugsbiopharmaceuticalscancercancer drug targets

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.6K

Related Experiment Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

9.8K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.6K

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Cancer presents a growing global health challenge with significant physical and psychological impacts.
  • Effective cancer therapies are crucial, necessitating a deep understanding of tumor markers and regulatory pathways.
  • Current treatments, including small-molecule drugs, are evolving with a rise in biopharmaceutical approvals.

Purpose of the Study:

  • To review potential molecular targets for novel anticancer drug development.
  • To discuss the clinical application and impact of approved anticancer biopharmaceutical drugs.
  • To identify current challenges and future perspectives in the field of cancer biotherapeutics.

Main Methods:

  • Literature review of existing cancer therapies and drug targets.
  • Analysis of approved biopharmaceutical drugs for cancer treatment.
  • Exploration of emerging trends and challenges in anticancer drug discovery.

    • Main Results:

    • Identified key regulatory pathways and molecular targets relevant for anticancer drug development.
    • Highlighted the increasing efficacy and patient life extension provided by approved biopharmaceutical agents.
    • Summarized the diverse mechanisms of action for current cancer therapies, including small-molecule drugs and biopharmaceuticals.

    Conclusions:

    • Biopharmaceutical drugs represent a significant advancement in cancer treatment, expanding therapeutic options.
    • Further research into specific pathways and targets is essential for developing more effective anticancer drugs.
    • Addressing current challenges and embracing future perspectives will drive innovation in oncology drug development.